Confronting the Delta Variant of SARS-CoV-2, Summer 2021.

Del Rio, Carlos; Malani, Preeti N; Omer, Saad B

Del Rio, Carlos; Malani, Preeti N; Omer, Saad B.

Del Rio C; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.
Malani PN; Hubert Department of Global Health, Rollins School of Public Health of Emory University, Atlanta, Georgia.
Omer SB; Department of Internal Medicine, Division of Infectious Diseases, University of Michigan, Ann Arbor.

JAMA ; 326(11): 1001-1002, 2021 Sep 21.

Article in English | MEDLINE | ID: covidwho-1361171

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/prevention & control; Immunization Programs; Immunogenicity, Vaccine; SARS-CoV-2; Antibodies, Viral; Humans; Immunocompromised Host; Seasons; United States; Vaccination/statistics & numerical data

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunization Programs / Immunogenicity, Vaccine / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Year: 2021 Document Type: Article Affiliation country: Jama.2021.14811

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google